Breakthrough Devices Program: Where’s the value?

To find out more about the FDA’s Breakthrough Devices Program and its potential value for your organization, please join Parexel’s MedTech Regulatory Strategy and Health Advances MedTech consulting leaders, along with medical device innovators who have been through the process, in this webinar-on-demand.

What you will learn:

  1. Motivations for, and expectations associated with being part of the Breakthrough Devices Program 
  2. Challenges and benefits of the program overall, beyond working more closely with the FDA
  3. Experiences throughout the process and implications for development and commercialization timelines
  4. Key lessons learned from those who’ve been through the process 
  5. Considerations for whether and how to pursue breakthrough status

Return to Insights Center

Related Insights

Blog

Optimize your CMC strategy: Five steps to avoid regulatory setbacks

May 15, 2025

Whitepaper

How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU

Jun 28, 2023

Article

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022

Playbook

Are you using real-world evidence?

Feb 1, 2023

Video

How to transition existing trials under EU-CTR

Feb 1, 2023

Webinar

How to navigate China’s regulatory environment

Feb 15, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Related Insights

Blog

Optimize your CMC strategy: Five steps to avoid regulatory setbacks

May 15, 2025

Whitepaper

How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU

Jun 28, 2023

Article

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022

Playbook

Are you using real-world evidence?

Feb 1, 2023

Video

How to transition existing trials under EU-CTR

Feb 1, 2023

Webinar

How to navigate China’s regulatory environment

Feb 15, 2023

Show more